Legal manufacturer and site status
Confirm the legal manufacturer, manufacturing, packaging and testing sites; authorization scope; applicable GMP evidence; inspection history; and document validity for the program under review.
Quality, regulatory & supply documentation
Product-specific evidence for qualified due diligence.
METRYVA CARE coordinates the exchange and review of quality, technical and supply information for a defined product, presentation, manufacturing source, market and partner role. Each document is assessed for relevance, currency and applicability to the program under review.
Quality principle
A quality review begins with exact product and site identity.
The assessment is anchored to the legal manufacturer, manufacturing and testing sites, dosage form, strength, presentation, batch status, storage conditions and target jurisdiction. Generic capability statements do not replace product-specific evidence.
Product definition and specifications
Confirm dosage form, strength, presentation, formulation, primary-container and device components, release and shelf-life specifications, labeling basis and intended storage conditions.
Analytical control strategy
Review identity, assay, purity, impurities, microbiological or endotoxin controls where applicable, reference standards, analytical procedures and evidence of method suitability.
Manufacturing and batch release
Review the manufacturing-process overview, in-process controls, executed batch and packaging records, certificate of analysis, deviation and OOS handling, data review and authorized release.
Stability, packaging and distribution
Review stability protocols and available data, shelf-life rationale, container-closure suitability, shipping qualification, labeled storage conditions, excursion assessment and cold-chain controls where required.
Lifecycle and post-market controls
Confirm change control, regulatory-impact assessment, CAPA, complaints, quality-defect escalation, safety-reporting interfaces, recall readiness, traceability and record retention.
Due-diligence pathway
Document depth follows the decision stage and agreed scope.
Confidential technical records are provided only after the requesting organization, product, jurisdiction and intended use have been qualified. Document lists are confirmed for the exact program rather than assumed from a generic template.
Counterparty and scope confirmation
Confirm the legal entities, product, manufacturing source, presentation, target jurisdiction, proposed role and purpose of the review.
Confidential technical assessment
Provide the product- and site-specific documents available for the agreed diligence scope under appropriate confidentiality and document-control conditions.
Quality and supply agreement
Before execution, assign responsibilities for release, change notification, storage, distribution, complaints, safety interfaces, recalls, audits, records and regulatory communication.
Quality responsibility matrix
Responsibilities remain controlled throughout the product lifecycle and supply chain.
The final allocation depends on local law, marketing-authorization status and the executed quality and supply agreements. Listing a function here does not mean METRYVA CARE performs that regulated function.
Manufacture, testing and batch release; data integrity; deviations and OOS investigations; CAPA; validation; stability; and controlled notification of relevant changes.
Local authorization, import and release requirements, labeling, regulatory maintenance, pharmacovigilance interfaces, product-quality reporting and recall coordination.
GDP-compliant receipt, storage and transport; temperature control; chain of custody; traceability; excursion and deviation handling; returns and recall execution.
Licensed receipt, storage, prescription or professional-use verification, dispensing controls, inventory records and escalation of complaints, defects and adverse events.
Counterparty qualification, document coordination, approved communication controls and confirmation that contractual responsibilities are assigned to the appropriate parties.
Reference framework
Public standards used to structure diligence questions.
The applicable legal and regulatory requirements of the target jurisdiction always take precedence. These sources are provided as recognized international reference points, not as claims of certification.
ICH Q10 — Pharmaceutical Quality SystemLifecycle pharmaceutical quality-system model.
Official sourceICH Q9(R1) — Quality Risk ManagementRisk-based principles across development, manufacturing and distribution.
Official sourceICH Q2(R2) — Validation of Analytical ProceduresEvidence that an analytical procedure is fit for its intended purpose.
Official sourceICH Q1A(R2) — Stability TestingEstablished stability-data principles, subject to current regional requirements.
Official sourceWHO TRS 1025, Annex 7Good storage and distribution practices for medical products.
Official sourceTechnical review
Define the product, site, jurisdiction and purpose before requesting documents.
Submit the legal entity, product or program, intended market and diligence purpose so the appropriate document scope and responsible parties can be identified.